JP2022007994A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022007994A5 JP2022007994A5 JP2021033150A JP2021033150A JP2022007994A5 JP 2022007994 A5 JP2022007994 A5 JP 2022007994A5 JP 2021033150 A JP2021033150 A JP 2021033150A JP 2021033150 A JP2021033150 A JP 2021033150A JP 2022007994 A5 JP2022007994 A5 JP 2022007994A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- optionally substituted
- alkyl
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025145992A JP2025175000A (ja) | 2020-03-04 | 2025-09-03 | 縮合三環性化合物及びその医薬用途 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020036931 | 2020-03-04 | ||
| JP2020036931 | 2020-03-04 | ||
| JP2021001452 | 2021-01-07 | ||
| JP2021001452 | 2021-01-07 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025145992A Division JP2025175000A (ja) | 2020-03-04 | 2025-09-03 | 縮合三環性化合物及びその医薬用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022007994A JP2022007994A (ja) | 2022-01-13 |
| JP2022007994A5 true JP2022007994A5 (enExample) | 2024-03-05 |
| JP7739012B2 JP7739012B2 (ja) | 2025-09-16 |
Family
ID=77613417
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021033150A Active JP7739012B2 (ja) | 2020-03-04 | 2021-03-03 | 縮合三環性化合物及びその医薬用途 |
| JP2025145992A Pending JP2025175000A (ja) | 2020-03-04 | 2025-09-03 | 縮合三環性化合物及びその医薬用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025145992A Pending JP2025175000A (ja) | 2020-03-04 | 2025-09-03 | 縮合三環性化合物及びその医薬用途 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20230025880A1 (enExample) |
| EP (2) | EP4116301B1 (enExample) |
| JP (2) | JP7739012B2 (enExample) |
| KR (1) | KR20220149688A (enExample) |
| CN (1) | CN115151543B (enExample) |
| AU (1) | AU2021230880A1 (enExample) |
| BR (1) | BR112022014749A2 (enExample) |
| CA (1) | CA3166747A1 (enExample) |
| CL (1) | CL2022002355A1 (enExample) |
| CO (1) | CO2022012548A2 (enExample) |
| DK (1) | DK4116301T3 (enExample) |
| FI (1) | FI4116301T3 (enExample) |
| HR (1) | HRP20251364T1 (enExample) |
| IL (1) | IL295836B1 (enExample) |
| LT (1) | LT4116301T (enExample) |
| MX (1) | MX2022010950A (enExample) |
| PE (1) | PE20221908A1 (enExample) |
| PH (1) | PH12022552259A1 (enExample) |
| PT (1) | PT4116301T (enExample) |
| TW (1) | TWI884224B (enExample) |
| WO (1) | WO2021177330A1 (enExample) |
| ZA (1) | ZA202209620B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7241556B2 (ja) * | 2018-02-01 | 2023-03-17 | 日本たばこ産業株式会社 | 含窒素複素環アミド化合物及びその医薬用途 |
| MX2022010950A (es) * | 2020-03-04 | 2022-10-07 | Japan Tobacco Inc | Compuesto triciclico fusionado y uso farmaceutico del mismo. |
| EP4438040A4 (en) * | 2021-09-01 | 2025-08-20 | Japan Tobacco Inc | NITROGEN-CONTAINING TRICYCLIC COMPOUND AND ITS PHARMACEUTICAL USE |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006522747A (ja) * | 2003-04-11 | 2006-10-05 | ノボ ノルディスク アクティーゼルスカブ | 縮合１，２，４−トリアゾールの薬学的使用 |
| US20050085531A1 (en) * | 2003-10-03 | 2005-04-21 | Hodge Carl N. | Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| KR100808551B1 (ko) * | 2006-12-01 | 2008-03-03 | 한국생명공학연구원 | 트리아졸 유도체를 유효성분으로 함유하는 대사성 질환 예방 및 치료용 약학적 조성물 |
| PL2975028T3 (pl) * | 2013-03-15 | 2018-10-31 | Japan Tobacco, Inc. | Związek pirazoloamidowy i jego zastosowania medyczne |
| US10526325B2 (en) | 2015-07-31 | 2020-01-07 | Merck Patent Gmbh | Bicyclic heterocyclic derivatives |
| JP7241556B2 (ja) * | 2018-02-01 | 2023-03-17 | 日本たばこ産業株式会社 | 含窒素複素環アミド化合物及びその医薬用途 |
| US20220362215A1 (en) | 2018-09-11 | 2022-11-17 | Japan Tobacco Inc. | Therapeutic or prophylactic agent for chronic kidney disease containing pyrazole-amide compound |
| MX2022010950A (es) | 2020-03-04 | 2022-10-07 | Japan Tobacco Inc | Compuesto triciclico fusionado y uso farmaceutico del mismo. |
-
2021
- 2021-03-03 MX MX2022010950A patent/MX2022010950A/es unknown
- 2021-03-03 HR HRP20251364TT patent/HRP20251364T1/hr unknown
- 2021-03-03 EP EP21764169.5A patent/EP4116301B1/en active Active
- 2021-03-03 JP JP2021033150A patent/JP7739012B2/ja active Active
- 2021-03-03 BR BR112022014749A patent/BR112022014749A2/pt unknown
- 2021-03-03 KR KR1020227032125A patent/KR20220149688A/ko active Pending
- 2021-03-03 PT PT217641695T patent/PT4116301T/pt unknown
- 2021-03-03 EP EP25206111.4A patent/EP4663189A2/en active Pending
- 2021-03-03 US US17/602,103 patent/US20230025880A1/en active Pending
- 2021-03-03 LT LTEPPCT/JP2021/008055T patent/LT4116301T/lt unknown
- 2021-03-03 WO PCT/JP2021/008055 patent/WO2021177330A1/ja not_active Ceased
- 2021-03-03 IL IL295836A patent/IL295836B1/en unknown
- 2021-03-03 AU AU2021230880A patent/AU2021230880A1/en active Pending
- 2021-03-03 CA CA3166747A patent/CA3166747A1/en active Pending
- 2021-03-03 PE PE2022001891A patent/PE20221908A1/es unknown
- 2021-03-03 PH PH1/2022/552259A patent/PH12022552259A1/en unknown
- 2021-03-03 FI FIEP21764169.5T patent/FI4116301T3/fi active
- 2021-03-03 TW TW110107548A patent/TWI884224B/zh active
- 2021-03-03 DK DK21764169.5T patent/DK4116301T3/da active
- 2021-03-03 CN CN202180018517.1A patent/CN115151543B/zh active Active
-
2022
- 2022-08-29 ZA ZA2022/09620A patent/ZA202209620B/en unknown
- 2022-08-29 CL CL2022002355A patent/CL2022002355A1/es unknown
- 2022-09-01 CO CONC2022/0012548A patent/CO2022012548A2/es unknown
-
2025
- 2025-09-03 JP JP2025145992A patent/JP2025175000A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022007994A5 (enExample) | ||
| JP2015524443A5 (enExample) | ||
| JP2019131544A5 (enExample) | ||
| JP2017504640A5 (enExample) | ||
| RU2429236C2 (ru) | Новая полиморфная форма и аморфная форма 5-хлор-n-({(5s)-2-оксо-3-[4-(3-оксо-4-морфолинил)-фенил]-1, 3-оксазолидин-5-ил}-метил)-2-тиофенкарбоксамида | |
| JPWO2020103815A5 (enExample) | ||
| JP2021516240A5 (enExample) | ||
| KR101615399B1 (ko) | 리바록사반 및 말론산의 신규 공결정 화합물 | |
| RU2008123055A (ru) | СОЛИ ИНГИБИТОРА ФАКТОРА Ха, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБ ЛЕЧЕНИЯ ТРОМБОЗА И СПОСОБ ИНГИБИРОВАНИЯ КОАГУЛЯЦИИ ОБРАЗЦОВ КРОВИ | |
| JP2019518036A5 (enExample) | ||
| RU2016101964A (ru) | СТИМУЛЯТОРЫ sGC | |
| JP2015533168A5 (enExample) | ||
| HRP20251364T1 (hr) | Kondenzirani triciklički spoj i njegova medicinska upotreba | |
| JP2019521111A5 (enExample) | ||
| JP2019518041A5 (enExample) | ||
| JP2019527215A5 (enExample) | ||
| JP2019521153A5 (enExample) | ||
| CN103270024B (zh) | 新的取代异喹啉衍生物 | |
| JP2013519665A (ja) | メシル酸イマチニブのα形の製造方法 | |
| JPWO2023032940A5 (enExample) | ||
| RU2015137972A (ru) | Новые производные дигидрохинолин-2-она в качестве ингибиторов альдостеронсинтазы (cyp1 1 b2 или cyp1 1 b1) | |
| JP2019507167A5 (enExample) | ||
| JP2008517954A (ja) | 抗血小板剤としての置換ピリドキシン | |
| JP2018522024A5 (enExample) | ||
| JP2007506679A5 (enExample) |